Platelet-activating factor interaction with the human erythrocyte membrane

Journal of Biochemical and Molecular Toxicology

Volumn 23, Issue 5, 2009, Pages 345-348

  Mrówczyńska, Lucyna ^a   Hägerstrand, Henry ^b  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

Amphiphile; Hemolysis; Human erythrocyte; PAF; Phosphatidylserine exposure; Shape alteration

Indexed keywords

2 ACETYL 1 O HEXADECYLGLYCEROPHOSPHORYLCHOLINE; PHOSPHATIDYLSERINE; PHOSPHORYLCHOLINE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL INTERACTION; CELL SHAPE; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ECHINOCYTOSIS; ERYTHROCYTE DISORDER; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; HUMAN EXPERIMENT; INTERCALATION COMPLEX; NORMAL HUMAN;

ANNEXIN A5; CELL SHAPE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE MEMBRANE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HEMOLYSIS; HUMANS; MOLECULAR STRUCTURE; PHOSPHATIDYLSERINES; PLATELET ACTIVATING FACTOR; TEMPERATURE; TIME FACTORS;

EID: 70350170538     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20297     Document Type: Article

References (27)

1. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 2000;69:419-445.
2. Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 2003;40:643-672.
3. Bussolino F, Arese M, Montrucchio G, Barra L, Primo L, Benelli R, Sanavio F, Aglietta M, Ghigo D, Rola-Pleszczynski MR, Bosia A, Albini A, Camussi G. Platelet activationg factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin Invest 1995;96:940-952.
4. Lynch JM, Lotner GZ, Betz SJ, Henson PM. The release of a platelet-activating factor by stimulated rabbit neutrophils. J Immunol. 1979;123:1219-1226. (Pubitemid 9229658)
5. O'Flaherty JT, Wykle RL, Miller CH, Lewis JC, Waite M, Bass DA, McCall CE, DeChatelet LR. 1-O-Alkyl-sn- glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. Am J Pathol 1981;103:70-78.
6. Tamura N, Agrawal DK, Suliman FA, Townley RG. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun 1987;142:638-644. (Pubitemid 17021083)
7. Lang PA, Kempe DS, Tanneur V, Eisele K, Klarl BA, Myssina S, Jendrossek V, Ishii S, Shimizu T, Waidmann M, Hessler G, Huber SM, Lang F, Wieder T. Stimulation of erythrocyte ceramide formation by platelet-activating factor. J Cell Sci 2005;118:1233-1243. (Pubitemid 40528693)
8. Kuliszkiewicz-Janus M, Tuz MA, Kielbiński M, Baczyński S, Jaźwiec B, Śladowska H. Platelet-activating factor changes in phospholipid extracts from the plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells of patients with acute leukemia- A 31P MRS in vitro study. Cell Mol Biol Lett 2008;13:58-66. (Pubitemid 351679944)
9. Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, Simons FE, Simons KJ, Cass D, Yeung J. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008;358:28-35.
10. Karasawa K. Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Biochim Biophys Acta 2006;1761:1359-1372. (Pubitemid 44738709)
11. Oh SO, Ibe BO, Johnson C, Kurantsin-Mills J, Raj JU. Platelet-activating factor in plasma of patients with sickle cell disease in steady state. J Lab Clin Med 1997;130:191-196. (Pubitemid 27370048)
12. Miwa M, Miyake T, Yamanaka T, Sugatani J, Suzuki Y, Sakata S, Araki Y, Matsumoto M. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest 1988;82:1983-1991. (Pubitemid 19054946)
13. Kasperska-Zajac C, Brzoza Z, Rogala B. Platelet activating factor as a mediator and therapeutic approach in bronchial asthma. Inflammation 2008;31:112-120.
14. Shin CR, Moores J, Best AM, Tew JG, Schenkein HA, Barbour SE. Differential platelet-activating factor synthesis by monocytes and polymorphonuclear leukocytes from subjects with localized aggressive periodontitis. J Peridontal Res 2007;42:202-211.
15. Kültürsay N, Kantar M, Akisü M, Hüseyinow A, Coker I. Patelet-activating factor concentration in healthy and septic neonates. Eur J Pediatr 1999;158:740-741. (Pubitemid 29390114)
16. Isomaa B, Hägerstrand H, Paatero G, Engblom AC. Permeability alterations and antihaemolysis induced by amphiphiles in human erythrocytes. Biochim Biophys Acta 1986;860:510-524. (Pubitemid 16027960)
17. Isomaa B, Hägerstrand H, Paatero G. Shape transformations induced by amphiphiles in erythrocytes. Biochim Biophys Acta 1987;899:930-1103 (Pubitemid 17116178)
18. 2+-induced shape alterations in erythrocytes - a study with lamprey (Lampetra fluviatilis), trout (Oncorhynchus mykiss) and human erythrocytes. Biochim Biophys Acta 2000;1466:125-138.
19. Hägerstrand H, Holmström T, Bobrowska-Hägerstrand M, Eriksson J, Isomaa B. Amphiphile-induced phosphatidylserine exposure in human erythrocytes. Mol Membr Biol 1998;15:89-95. (Pubitemid 28391078)
20. Bessis M. Red cell shape. In: Bessis M, Weed RI, Leblond PF, editors. Red cell shape physiology, pathology, ultrastructure. Heidelberg, W. Germany: Spinger-Verlag; 1973. pp 1-24.
21. Hägerstrand H, Isomaa B. Amphiphile-induced antihaemolysis is not causally related to shape changes and vesiculation. Chem Biol Inter 1991;79:335-347.
22. Sheetz MP, Singer SJ. Biological membranes as bilayer couples. Amolecularmechanism of drug-erythrocyte interactions. Proc Natl Acad Sci 1974;71:4457-4461.
23. Sheetz MP, Singer SJ. Equilibrium and kinetic effects of drugs on the shape of human erythrocytes. J Cell Biol 1976;70:247-251.
24. Stafforini DM, Rollins EN, Prescott SM, McIntyre TM. The platelet-activating factor acetylhydrolase from human erythrocytes. J Biol Chem 1993;268:3857-3865.
25. Karasawa K, Shiarakura M, Harada A, Satoh N, Yokoyama K, Setaka M, Inoue K. Red blood cells highly express type I platelet-activating factor-acetylhydrolase (PAF-AH) which consists of the α1/α2 complex. J Biochem 2005;138:509-517. (Pubitemid 41703705)
26. Kuypers FA, Lewis RA, Hua M, Scott MA, Diswher D, Ernst JD, Lubin BH. Detection of alteredmembrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 1996;87:1179-1187. (Pubitemid 26043547)
27. Pantaler E, Kamp D, Haest CWM. Acceleration of phospholipid flip-flop in the erythrocyte membrane by detergents differing in polar headgroup and alkyl chain length. Biochim Biophys Acta 2000;1509:397-408.